<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Spero Science Innovation]]></title><description><![CDATA[Translational biotech company in São Paulo, Brazil, developing cell therapy, cartilage regeneration and AI diagnostics for musculoskeletal health.]]></description><link>https://www.spero-science.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Sat, 12 Sep 2026 17:12:12 GMT</lastBuildDate><atom:link href="https://www.spero-science.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Seja Parceiro da Spero Science: Investimento, Licenciamento e Colaboração em Ortopedia Regenerativa]]></title><description><![CDATA[Um guia para investidores, fundos de venture capital, empresas farmacêuticas e de dispositivos médicos, hospitais e instituições de pesquisa que querem trabalhar com a Spero Science Innovation — o que estamos construindo, em que estágio está cada plataforma e as formas de colaborar.]]></description><link>https://www.spero-science.com/pt-br/post/seja-parceiro-spero-science-investidores</link><guid isPermaLink="false">6aa58205a483818419b76d4e</guid><pubDate>Sat, 12 Sep 2026 17:00:19 GMT</pubDate><dc:creator>Prof. Dr. Tiago Lazzaretti Fernandes</dc:creator></item><item><title><![CDATA[Da Bancada da USP à Clínica: Como uma Biotech Translacional Brasileira Constrói Terapias Regenerativas]]></title><description><![CDATA[O que "translacional" realmente significa na Spero Science — o ecossistema paulista da USP, do HC-FMUSP e do Hospital Sírio-Libanês, os parceiros de fomento e inovação por trás dele, o caminho da ANVISA para terapias avançadas e por que o Brasil é uma base estratégica para a medicina regenerativa musculoesquelética.]]></description><link>https://www.spero-science.com/pt-br/post/biotech-translacional-brasil-da-usp-a-clinica</link><guid isPermaLink="false">6aa581e42b9824cfeea8f5a5</guid><pubDate>Sat, 12 Sep 2026 16:58:47 GMT</pubDate><dc:creator>Prof. Dr. Tiago Lazzaretti Fernandes</dc:creator></item><item><title><![CDATA[IA Multimodal para Diagnóstico Musculoesquelético: Integrando Imagem, Genética e Dados do Paciente]]></title><description><![CDATA[Por que a próxima geração de IA em ortopedia não vai apenas ler imagens — como a Spero Science AI integra ressonância e radiografia, perfis genéticos e desfechos relatados pelo paciente para prever quem vai progredir, quem vai responder ao tratamento e quem precisa de cirurgia.]]></description><link>https://www.spero-science.com/pt-br/post/ia-multimodal-diagnostico-musculoesqueletico</link><guid isPermaLink="false">6aa581a45669063752700f84</guid><pubDate>Sat, 12 Sep 2026 16:56:42 GMT</pubDate><dc:creator>Prof. Dr. Tiago Lazzaretti Fernandes</dc:creator></item><item><title><![CDATA[Terapia Celular para Osteoartrite do Joelho: O Que a Evidência Randomizada Realmente Diz]]></title><description><![CDATA[Uma leitura em linguagem clara da metanálise de 2024 com 25 ensaios randomizados sobre terapia com células estromais mesenquimais para osteoartrite do joelho, liderada pelos fundadores da Spero Science — o que funciona, o que é incerto e por que a fabricação em GMP e a engenharia de tecidos são o próximo passo.]]></description><link>https://www.spero-science.com/pt-br/post/terapia-celular-osteoartrite-joelho-evidencia</link><guid isPermaLink="false">6aa5813c26185f4bcc566c28</guid><pubDate>Sat, 12 Sep 2026 16:55:14 GMT</pubDate><dc:creator>Prof. Dr. Tiago Lazzaretti Fernandes</dc:creator></item><item><title><![CDATA[Regeneração de Cartilagem sem Cirurgia: Como Funcionam as Terapias Condroindutoras]]></title><description><![CDATA[Por que a cartilagem articular não cicatriza sozinha, o que significa "condroindução" e como uma molécula condroindutora injetável pode tratar a osteoartrite e as lesões condrais focais sem cirurgia aberta — a ciência por trás da principal plataforma da Spero Science.]]></description><link>https://www.spero-science.com/pt-br/post/regeneracao-de-cartilagem-sem-cirurgia-terapia-condroindutora</link><guid isPermaLink="false">6aa580e75347e70caff2aa19</guid><pubDate>Sat, 12 Sep 2026 16:53:33 GMT</pubDate><dc:creator>Prof. Dr. Tiago Lazzaretti Fernandes</dc:creator></item><item><title><![CDATA[Partner with Spero Science: Investment, Licensing and Collaboration in Regenerative Orthopedics]]></title><description><![CDATA[A guide for investors, venture funds, pharmaceutical and medical-device companies, hospitals and research institutions who want to work with Spero Science Innovation — what we are building, what stage each platform is at, and the ways to collaborate.]]></description><link>https://www.spero-science.com/post/partner-with-spero-science-investors</link><guid isPermaLink="false">6aa55fb7f448a9cd17b60f54</guid><pubDate>Sat, 12 Sep 2026 14:20:39 GMT</pubDate><dc:creator>Prof. Dr. Tiago Lazzaretti Fernandes</dc:creator></item><item><title><![CDATA[From the USP Bench to the Clinic: How a Brazilian Translational Biotech Builds Regenerative Therapies]]></title><description><![CDATA[What "translational" really means at Spero Science — the São Paulo ecosystem of USP, HC-FMUSP and Hospital Sírio-Libanês, the funding and innovation partners behind it, the ANVISA pathway for advanced therapies, and why Brazil is a strategic base for musculoskeletal regenerative medicine.]]></description><link>https://www.spero-science.com/post/translational-biotech-brazil-usp-to-clinic</link><guid isPermaLink="false">6aa55f741be24c419fd0ecec</guid><pubDate>Sat, 12 Sep 2026 14:19:32 GMT</pubDate><dc:creator>Prof. Dr. Tiago Lazzaretti Fernandes</dc:creator></item><item><title><![CDATA[Multimodal AI for Musculoskeletal Diagnosis: Combining Imaging, Genetics and Patient Data]]></title><description><![CDATA[Why the next generation of orthopedic AI will not read images alone — how Spero Science AI integrates MRI and X-ray, genetic profiles and patient-reported outcomes to predict who will progress, who will respond to treatment and who needs surgery.]]></description><link>https://www.spero-science.com/post/multimodal-ai-musculoskeletal-diagnosis</link><guid isPermaLink="false">6aa55f17f448a9cd17b60e20</guid><pubDate>Sat, 12 Sep 2026 14:17:59 GMT</pubDate><dc:creator>Prof. Dr. Tiago Lazzaretti Fernandes</dc:creator></item><item><title><![CDATA[Cell Therapy for Knee Osteoarthritis: What the Randomized Evidence Actually Says]]></title><description><![CDATA[A plain-language reading of the 2024 meta-analysis of 25 randomized trials on mesenchymal stromal cell therapy for knee osteoarthritis, led by Spero Science's founders — what works, what is uncertain, and why GMP manufacturing and tissue engineering are the next step.]]></description><link>https://www.spero-science.com/post/cell-therapy-knee-osteoarthritis-evidence</link><guid isPermaLink="false">6aa55edddd58bcb58cb740b1</guid><pubDate>Sat, 12 Sep 2026 14:17:01 GMT</pubDate><dc:creator>Prof. Dr. Tiago Lazzaretti Fernandes</dc:creator></item><item><title><![CDATA[Cartilage Regeneration Without Surgery: How Chondroinductive Therapies Work]]></title><description><![CDATA[Why articular cartilage does not heal on its own, what "chondroinduction" means, and how an injectable chondroinductive molecule could treat osteoarthritis and focal cartilage lesions without open surgery — the science behind Spero Science's lead platform.]]></description><link>https://www.spero-science.com/post/cartilage-regeneration-without-surgery-chondroinductive-therapy</link><guid isPermaLink="false">6aa55e8b1be24c419fd0eb02</guid><pubDate>Sat, 12 Sep 2026 14:15:40 GMT</pubDate><dc:creator>Prof. Dr. Tiago Lazzaretti Fernandes</dc:creator></item></channel></rss>